Public-sector contracts won via EU procurement (TED).
| Buyer | Contract | Value | Date |
|---|---|---|---|
| Latvijas Biozinātņu un tehnoloģiju universitāte | Asins un urīna paraugu laboratoriskās izmeklēšanas pakalpojumi LBTU Veterinārās klīnikas vajadzībām | €10 000 | 2026. gada 17. jūnijs |
| Nacionālais veselības dienests | Līgums par līguma Nr. NVD-5/17-2021 ietvaros ārstniecības iestādēm un iedzīvotājiem izsniegto kolorektālā vēža skrīninga testa komplektu loģistiku un paraugu izmeklēšanu | €147 166 | 2026. gada 17. janvāris |
| Latvijas Biozinātņu un tehnoloģiju universitāte | Asins un urīna paraugu laboratoriskās izmeklēšanas pakalpojumi LBTU Veterinārās klīnikas vajadzībām | €10 000 | 2024. gada 17. jūnijs |
| Latvijas Biozinātņu un tehnoloģiju universitāte | Glikozes un lipīdu noteikšana asins paraugos LBTU vajadzībām | €3000 | 2024. gada 6. marts |
| Sabiedrība ar ierobežotu atbildību “Rēzeknes slimnīca” | Laboratorisko pakalpojumu sniegšana SIA "RĒZEKNES SLIMNĪCA" vajadzībām | €1 008 870 | 2024. gada 29. februāris |
| year | 2024Latest | 2023 | 2022 |
|---|---|---|---|
Revenue | 40,5m € +21.0% | 33,5m € -49.9% | 66,8m € -3.4% |
Profit | 8,9m € +106.3% | 4,3m € -83.9% | 26,9m € +24.0% |
Assets | 64,4m € +8.2% | 59,5m € +1.0% | 58,9m € +77.0% |
Liabilities | 5,7m € +33.2% | 4,3m € -12.8% | 4,9m € -6.6% |
Equity | 58,7m € +6.3% | 55,2m € +2.2% | 54m € +92.6% |
Employees | 662 +3.0% | 643 -16.6% | 771 +3.8% |
Overall rating | A+99/100 |
Financial health | 100/100 |
Credit history | 100/100 |
Legal history | 100/100 |
Business activity | 95/100 |
| Overall risk | Low |
No risk flags | |
No tax debts | |
Regular report filing | |
Positive equity | |
Can cover short-term debts | |
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 32 years | 1 - 5 | 71% | |
Net revenue | 40 538 925,00 € | 1 - 4 | 86% | |
Profit | 8 902 278,00 € | 1 - 3 | 100% | |
Equity | 58 723 799,00 € | 1 - 3 | 100% | |
Assets | 64 426 309,00 € | 1 - 3 | 100% | |
Fixed assets | 18 508 041,00 € | - | 90% | |
Investments | 30 073 148,00 € | - | 90% | |
Liquidity | 2.89 | - | 75% | |
Profitability | 22.0% | - | 50% | |
Registered capital | 3000,00 € | - | 10% |
| Name, surname | Birth date | Position | Representation rights | Registered | |
|---|---|---|---|---|---|
| Board chairman | Independently | ||||
| Board member | Independently |
SIA Balvu un Gulbenes slimnīcu attīstības fonds (40203200242)
Sabiedrība ar ierobežotu atbildību "CENTRĀLĀ LABORATORIJA" is located at Rīga, Grēdu iela 4A, LV-1019.
In 2024, Sabiedrība ar ierobežotu atbildību "CENTRĀLĀ LABORATORIJA" had revenue of 40 538 925 € and profit of 8 902 278 €. Compared to previous year, revenue increased by 21.0%. View full financial report →
Sabiedrība ar ierobežotu atbildību "CENTRĀLĀ LABORATORIJA"'s estimated company value is calculated from its publicly filed financial statements, using earnings, revenue, asset-based and discounted-cash-flow methods. See full valuation →
In 2024, Sabiedrība ar ierobežotu atbildību "CENTRĀLĀ LABORATORIJA" had an average of 647 employees. View tax history →
The beneficial owners of Sabiedrība ar ierobežotu atbildību "CENTRĀLĀ LABORATORIJA" are Andrejs Leibovičs, Roberts Tavjevs and Sergejs Korņijenko. View ownership details →
Yes, Sabiedrība ar ierobežotu atbildību "CENTRĀLĀ LABORATORIJA" is registered as an active VAT payer with VAT number LV40003210801.
In 2024, the average gross salary at Sabiedrība ar ierobežotu atbildību "CENTRĀLĀ LABORATORIJA" was approximately 1213,13 € per month (net ~ 938,93 €). This is an approximate calculation. View salary details →
Sabiedrība ar ierobežotu atbildību "CENTRĀLĀ LABORATORIJA" was founded on August 17, 1994. The company has been operating for 32 years.
In 2024, Sabiedrība ar ierobežotu atbildību "CENTRĀLĀ LABORATORIJA" had revenue of 40.5 million € and profit of 8.9 million €. The company has 647 employees. Beneficial owners: Andrejs Leibovičs, Roberts Tavjevs, Sergejs Korņijenko.
| Name, surname | Shares | Ownership rights | |
|---|---|---|---|
| AS "Repharm" | 3000 | 100.00% |
| Name, surname | Nationality | Birth date | |
|---|---|---|---|
| Andrejs Leibovičs | LV | ||
| Roberts Tavjevs | LV | ||
| Sergejs Korņijenko | LV |
| Name | Registration number | Relationship |
|---|---|---|
| SIA "RPH INVEST" | 40203507493 | Subsidiary |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Annual financial report for 2020.
Annual financial report for 2019.
Registered in the Latvian company register.